These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


275 related items for PubMed ID: 24913037

  • 1. The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.
    Linher-Melville K, Singh G.
    BMC Cancer; 2014 Jun 09; 14():415. PubMed ID: 24913037
    [Abstract] [Full Text] [Related]

  • 2. Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.
    Linher-Melville K, Haftchenary S, Gunning P, Singh G.
    Mol Cell Biochem; 2015 Jul 09; 405(1-2):205-21. PubMed ID: 25896132
    [Abstract] [Full Text] [Related]

  • 3. Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.
    Fang F, Rycyzyn MA, Clevenger CV.
    Endocrinology; 2009 Apr 09; 150(4):1597-606. PubMed ID: 19036881
    [Abstract] [Full Text] [Related]

  • 4. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
    Neilson LM, Zhu J, Xie J, Malabarba MG, Sakamoto K, Wagner KU, Kirken RA, Rui H.
    Mol Endocrinol; 2007 Sep 09; 21(9):2218-32. PubMed ID: 17550976
    [Abstract] [Full Text] [Related]

  • 5. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
    Sinha S, Sharma S, Vora J, Shah H, Srivastava A, Shrivastava N.
    J Ethnopharmacol; 2018 May 10; 217():23-35. PubMed ID: 29427634
    [Abstract] [Full Text] [Related]

  • 6. Liver kinase B1 expression (LKB1) is repressed by estrogen receptor alpha (ERα) in MCF-7 human breast cancer cells.
    Linher-Melville K, Zantinge S, Singh G.
    Biochem Biophys Res Commun; 2012 Jan 20; 417(3):1063-8. PubMed ID: 22226967
    [Abstract] [Full Text] [Related]

  • 7. Induction of multidrug resistance transporter ABCG2 by prolactin in human breast cancer cells.
    Wu AM, Dalvi P, Lu X, Yang M, Riddick DS, Matthews J, Clevenger CV, Ross DD, Harper PA, Ito S.
    Mol Pharmacol; 2013 Feb 20; 83(2):377-88. PubMed ID: 23150485
    [Abstract] [Full Text] [Related]

  • 8. Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
    Linher-Melville K, Zantinge S, Sanli T, Gerstein H, Tsakiridis T, Singh G.
    BMC Cancer; 2011 Feb 04; 11():56. PubMed ID: 21294903
    [Abstract] [Full Text] [Related]

  • 9. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
    Kavarthapu R, Tsai Morris CH, Dufau ML.
    Oncotarget; 2014 Oct 15; 5(19):9079-91. PubMed ID: 25193864
    [Abstract] [Full Text] [Related]

  • 10. PRL activates the cyclin D1 promoter via the Jak2/Stat pathway.
    Brockman JL, Schroeder MD, Schuler LA.
    Mol Endocrinol; 2002 Apr 15; 16(4):774-84. PubMed ID: 11923474
    [Abstract] [Full Text] [Related]

  • 11. STAT5 and prolactin participate in a positive autocrine feedback loop that promotes angiogenesis.
    Yang X, Meyer K, Friedl A.
    J Biol Chem; 2013 Jul 19; 288(29):21184-21196. PubMed ID: 23729680
    [Abstract] [Full Text] [Related]

  • 12. SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL.
    Barclay JL, Anderson ST, Waters MJ, Curlewis JD.
    Int J Cancer; 2009 Apr 15; 124(8):1756-66. PubMed ID: 19115200
    [Abstract] [Full Text] [Related]

  • 13. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
    Sultan AS, Brim H, Sherif ZA.
    Cancer Sci; 2008 Feb 15; 99(2):272-9. PubMed ID: 18271926
    [Abstract] [Full Text] [Related]

  • 14. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
    Dagvadorj A, Collins S, Jomain JB, Abdulghani J, Karras J, Zellweger T, Li H, Nurmi M, Alanen K, Mirtti T, Visakorpi T, Bubendorf L, Goffin V, Nevalainen MT.
    Endocrinology; 2007 Jul 15; 148(7):3089-101. PubMed ID: 17412813
    [Abstract] [Full Text] [Related]

  • 15. Prolactin/Stat5 and androgen R1881 coactivate carboxypeptidase-D gene in breast cancer cells.
    Koirala S, Thomas LN, Too CK.
    Mol Endocrinol; 2014 Mar 15; 28(3):331-43. PubMed ID: 24433040
    [Abstract] [Full Text] [Related]

  • 16. Hwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2/STAT pathways in breast cancer xenografts.
    Park JH, Darvin P, Lim EJ, Joung YH, Hong DY, Park EU, Park SH, Choi SK, Moon ES, Cho BW, Park KD, Lee HK, Kim MJ, Park DS, Chung IM, Yang YM.
    PLoS One; 2012 Mar 15; 7(7):e40531. PubMed ID: 22792362
    [Abstract] [Full Text] [Related]

  • 17. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor.
    Carsol JL, Gingras S, Simard J.
    Mol Endocrinol; 2002 Jul 15; 16(7):1696-710. PubMed ID: 12089361
    [Abstract] [Full Text] [Related]

  • 18. Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis-Regulatory Landscape Exploitable in ER+ Breast Cancer.
    Craig JM, Turner TH, Harrell JC, Clevenger CV.
    Endocrinology; 2021 May 01; 162(5):. PubMed ID: 33589921
    [Abstract] [Full Text] [Related]

  • 19. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
    Tran TH, Utama FE, Lin J, Yang N, Sjolund AB, Ryder A, Johnson KJ, Neilson LM, Liu C, Brill KL, Rosenberg AL, Witkiewicz AK, Rui H.
    Cancer Res; 2010 Feb 15; 70(4):1711-21. PubMed ID: 20124477
    [Abstract] [Full Text] [Related]

  • 20. Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells.
    Russell DL, Richards JS.
    Mol Endocrinol; 1999 Dec 15; 13(12):2049-64. PubMed ID: 10598581
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.